neoadjuvant
Showing 1 - 25 of 4,552
Esophageal Cancer Trial in Moscow (Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.,
Recruiting
- Esophageal Cancer
- Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
- Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy
-
Moscow, Russian FederationN.N. Blokhin National Medical Research Center of Oncology
Sep 19, 2022
Neoadjuvant Chemo, PD-1 Antibody, Radiotherapy Trial (neoadjuvant chemo combined with PD-1 antibody + radical radiotherapy)
Not yet recruiting
- Neoadjuvant Chemotherapy
- +3 more
- neoadjuvant chemotherapy combined with PD-1 antibody + radical radiotherapy
- (no location specified)
Sep 21, 2022
Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB
Recruiting
- Non Small Cell Lung Cancer
- anti-PD-1 or anti-PD-L1
- +2 more
-
Shanghai, ChinaOncology Department, Shanghai Chest Hospital
Jul 26, 2022
Rectal Cancer Trial in Shanghai (Total Neoadjuvant Chemoradiotherapy)
Recruiting
- Rectal Cancer
- Total Neoadjuvant Chemoradiotherapy
-
Shanghai, Shanghai, ChinaFudan University Zhongshan Hospital
Sep 28, 2022
Locally Advanced Esophageal Carcinoma Trial in Nanjing (Neoadjuvant Chemotherapy, Neoadjuvant Toripalimab, Short Course
Recruiting
- Locally Advanced Esophageal Carcinoma
- Neoadjuvant Chemotherapy
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital /Jiangsu Institute of Cancer Research
Jun 21, 2022
Rectal Cancer in a Tertiary Asian Institute
Completed
- Rectal Cancer
- Oncology
- neoadjuvant long course chemoradiotherapy
- (no location specified)
Oct 31, 2022
Advanced Gastric Carcinoma, CD8+ Tumor Infiltrating Lymphocytes, Neoadjuvant Immunotherapy Trial (radical surgery after
Not yet recruiting
- Advanced Gastric Carcinoma
- +2 more
- radical surgery after neoadjuvant immunotherapy
- radical surgery after neoadjuvant chemotherapy
- (no location specified)
Feb 26, 2022
Breast Tumors Trial in Shanghai (Neoadjuvant radiotherapy)
Recruiting
- Breast Neoplasms
- Neoadjuvant radiotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 28, 2022
Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Neoadjuvant Chemoimmunotherapy
- neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
- (no location specified)
Feb 14, 2023
Pancreatic Cancer Trial in Shanghai (Neoadjuvant gemcitabine plus nab-paclitaxel, Neoadjuvant gemcitabine plus nab-paclitaxel
Recruiting
- Pancreatic Cancer
- Neoadjuvant gemcitabine plus nab-paclitaxel
- +2 more
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 8, 2022
Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)
Recruiting
- Esophageal Carcinoma
- Neoadjuvant Immunotherapy
- PD-1 blockade
- +2 more
-
Beijing, Beijing, ChinaQin li
Mar 8, 2023
Renal Cell Carcinoma Trial (Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy,
Not yet recruiting
- Renal Cell Carcinoma
- Neoadjuvant Lenvatinib
- +3 more
- (no location specified)
Jun 28, 2022
Rectal Cancer Trial in Alexandria (radiation, drug, procedure)
Completed
- Rectal Cancer
- Radiotherapy
- +2 more
-
Alexandria, EgyptAhmed Samir Ashoor
Mar 7, 2022
Stage II-III Breast Cancer Trial in Shenyang (cytotoxic chemo (docetaxel or epirubicin or cyclophosphamide or carboplatin),
Recruiting
- Stage II-III Breast Cancer
- cytotoxic chemotherapy (docetaxel or epirubicin or cyclophosphamide or carboplatin)
- +2 more
-
Shenyang, Liaoning, China
- +1 more
Aug 3, 2022
Breast Cancer Trial in Nanjing (Neoadjuvant therapy: TCbHPy, Neoadjuvant therapy: TCbHP)
Not yet recruiting
- Breast Cancer
- Neoadjuvant therapy: TCbHPy
- Neoadjuvant therapy: TCbHP
-
Nanjing, Chinathe First Affiliated Hospital of Nanjing Medical University
Jul 4, 2022
Neoadjuvant Therapy Trial (standard long-term therapy, FOLFOX and standard long-term radiotherapy, FOLFIRI and standard
Not yet recruiting
- Neoadjuvant Therapy
- standard long-term therapy
- +5 more
- (no location specified)
Apr 22, 2022
Cell-in-cell Structure in Breast Cancer Undergoing Neoadjuvant
Recruiting
- Breast Neoplasms
- Neoadjuvant therapy
-
Beijing, Beijing, ChinaBeijing Shijitan Hospital, Capital Medical University
Dec 6, 2022
Immunotherapy, Analgesia, NSCLC Trial in Tianjin (neoadjuvant immunotherapy, Neoadjuvant chemo)
Not yet recruiting
- Immunotherapy
- +3 more
- neoadjuvant immunotherapy
- Neoadjuvant chemotherapy
- (no location specified)
Mar 1, 2022
Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)
Recruiting
- Neoadjuvant Chemoradiation Therapy
- +3 more
- xintilimab injection
- Control
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery in Changhai Hospital
Aug 5, 2022
Gastric Cancer Trial (Pre-rehabilitation, Standard medical care)
Not yet recruiting
- Gastric Cancer
- Pre-rehabilitation
- Standard medical care
- (no location specified)
Jul 24, 2022
Adenocarcinoma of Esophagogastric Junction Trial in Beijing (neoadjuvant Radiation plus SOX and PD-1 antibody)
Not yet recruiting
- Adenocarcinoma of Esophagogastric Junction
- neoadjuvant Radiation plus SOX and PD-1 antibody
-
Beijing, Beijing, ChinaPeking University People's Hospital
Aug 15, 2022
Gastric Cancer Trial in Fuzhou (response to neoadjuvant chemo)
Completed
- Gastric Cancer
- response to neoadjuvant chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of Gastric Surgery
Jul 15, 2022
Soft Tissue Sarcoma, Adult Soft Tissue Sarcoma, Resectable Soft Tissue Sarcoma Trial in Lyon (radiation, other, procedure)
Not yet recruiting
- Soft Tissue Sarcoma
- +2 more
- Neoadjuvant RT
- +3 more
-
Lyon, Rhône, FranceCentre Léon Bérard
Jan 12, 2023
Renal Cell Carcinoma Trial in Amsterdam, London (Neoadjuvant nivolumab, Neoadjuvant ipilimumab, Neoadjuvant relatlimab)
Recruiting
- Renal Cell Carcinoma
- Neoadjuvant nivolumab
- +2 more
-
Amsterdam, NH, Netherlands
- +1 more
May 3, 2022